LifeMine Therapeutics
Develops fungal genome-derived therapeutics for organ transplant rejection
$263MSeries D+Series E
Role not disclosedRC
RA Capital Management
Activity from announced rounds
Activity in this selectionHealthtech
RA Capital Management founds, funds and scales companies in healthcare and planetary health, combining scientific research with capital from seed through public-market financings.
Its TechAtlas research platform informs investment decisions through detailed scientific and market analysis. Raven, its healthcare incubator, works on originating and co-creating companies, giving researchers a route from a scientific idea to a funded business.
Blackbird provides a clinical development accelerator alongside the investment platform. These capabilities are relevant for founders who need to design a development programme and reach clinical milestones, as well as finance laboratory or commercial work.
Sources
- Rounds participated in
- 9
- Confirmed lead rounds
- — 9 roles undisclosed
- New companies
- 9 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.3B 9 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
9 in this selectionCelea Therapeutics
Develops treatments for serious respiratory diseases
$180MGrowth
Role not disclosedOllin Biosciences
Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD
$330MSeries B
Role not disclosedNorthLinks Bio
Develops broad-spectrum antiviral prophylactic therapies for respiratory infections
$34MUndisclosed
Role not disclosedContraline
Develops hormonal and non-hormonal male contraceptives for men and couples globally
$92.5MSeries B
Role not disclosedSecretome Therapeutics
Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy
$30MSeries A
Role not disclosedCellCentric
Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma
$220MSeries D
Role not disclosedNexCure
Provides CAR-T and other advanced treatment delivery in community outpatient settings
$19MSeries A
Role not disclosedSlate Medicines
Advancing next-generation therapeutics for migraine and other headache disorders
$130MSeries A
Role not disclosed